Clinical Trials Directory

Trials / Completed

CompletedNCT02012036

Study To Optimize Photodynamic Transurethral Resection of the Bladder (TUR-B) In Clinical Practice

OPTIC-III Prospective Non-Interventional Study To Optimize Photodynamic TUR-B In Clinical Practice

Status
Completed
Phase
Study type
Observational
Enrollment
400 (actual)
Sponsor
Ipsen · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of the study is to assess additional detection of Non-Muscle-Invasive Bladder Cancer (NMIBC) with hexyl aminolevulinate (HAL) cystoscopy based on lesions in patients undergoing TUR-B compared to white-light cystoscopy under the conditions of daily clinical practice.

Conditions

Interventions

TypeNameDescription
DRUGHexvixAs this is a non-interventional study, detection of NMIBC with Hexvix is in a pre-defined group, chosen prior to and independently from the decision to enrol the subject in this study. The detection with Hexvix should be in accordance with local Summary of Product Characteristics \[SmPC\]. Subjects will be treated in accordance with usual medical practice during their participation in this study, no additional assessment or tests will be required.

Timeline

Start date
2013-07-01
Primary completion
2014-07-01
Completion
2014-07-01
First posted
2013-12-16
Last updated
2019-08-16

Locations

2 sites across 1 country: Germany

Source: ClinicalTrials.gov record NCT02012036. Inclusion in this directory is not an endorsement.

Study To Optimize Photodynamic Transurethral Resection of the Bladder (TUR-B) In Clinical Practice (NCT02012036) · Clinical Trials Directory